Cargando…
Advances in mesenchymal stromal cell therapy for acute lung injury/acute respiratory distress syndrome
Acute lung injury (ALI)/acute respiratory distress syndrome (ARDS) develops rapidly and has high mortality. ALI/ARDS is mainly manifested as acute or progressive hypoxic respiratory failure. At present, there is no effective clinical intervention for the treatment of ALI/ARDS. Mesenchymal stromal ce...
Autores principales: | Liu, Chang, Xiao, Kun, Xie, Lixin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9399751/ https://www.ncbi.nlm.nih.gov/pubmed/36036014 http://dx.doi.org/10.3389/fcell.2022.951764 |
Ejemplares similares
-
Safety and efficacy of clinical-grade, cryopreserved menstrual blood mesenchymal stromal cells in experimental acute respiratory distress syndrome
por: Alcayaga-Miranda, Francisca, et al.
Publicado: (2023) -
Using Dictyostelium to Develop Therapeutics for Acute Respiratory Distress Syndrome
por: Kirolos, Sara A., et al.
Publicado: (2021) -
Documenting the immune response in patients with COVID-19-induced acute respiratory distress syndrome
por: Lu, Junyu, et al.
Publicado: (2023) -
Persistency of Mesenchymal Stromal/Stem Cells in Lungs
por: Ferrini, Erica, et al.
Publicado: (2021) -
Single-cell analysis reveals dysregulated inflammatory response in peripheral blood immunity in patients with acute respiratory distress syndrome
por: Mo, Jingjia, et al.
Publicado: (2023)